他汀类药物干预支架内再狭窄的研究进展

被引：20

作者：

邹佳妮

樊光辉

机构：

[1] 广州军区武汉总医院心血管内科

来源：

华南国防医学杂志 | 2010年 / 24卷 / 05期

关键词：

他汀类药物; 冠心病; 冠状动脉支架内再狭窄; 脂联素;

D O I：

10.13730/j.1009-2595.2010.05.012

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

100201 [内科学];

摘要：

引用

页码：424 / 427

页数：4

共 10 条

[1]

他汀类药物的非调脂作用 [J].

刘时武 ;

丁世芳 .

华南国防医学杂志, 2008, (02) :63-65

[2]

血管支架内再狭窄的研究进展 [J].

潘长江 ;

王进 ;

黄楠 .

中国生物医学工程学报, 2004, (02) :152-156

[3]

Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and Meta-Analysis of Women From Primary Prevention Trials [J].

Mora, Samia ;

Glynn, Robert J. ;

Hsia, Judith ;

MacFadyen, Jean G. ;

Genest, Jacques ;

Ridker, Paul M. .

CIRCULATION, 2010, 121 (09) :1069-1077

[4]

Effect of Atorvastatin Versus Rosuvastatin on Levels of Serum Lipids, Inflammatory Markers and Adiponectin in Patients with Hypercholesterolemia [J].

Qu, Hai-yan ;

Xiao, Ya-wei ;

Jiang, Gui-hua ;

Wang, Zhi-yun ;

Zhang, Yun ;

Zhang, Mei .

PHARMACEUTICAL RESEARCH, 2009, 26 (04) :958-964

[5]

Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling:: Role for the urokinase receptor [J].

Kiyan, Julia ;

Kusch, Angelika ;

Tkachuk, Sergey ;

Kraemer, Jochen ;

Haller, Hermann ;

Dietz, Rainer ;

Smith, Graham ;

Dumler, Inna .

ATHEROSCLEROSIS, 2007, 195 (02) :254-261

[6]

The Pathophysiology and Burden of Restenosis.[J].William S. Weintraub.The American Journal of Cardiology.2007, 5

[7]

Serum adiponectin concentration: Its correlation with diabetes-related traits and quantitative trait loci analysis in mouse SMXA recombinant inbred strains [J].

Kobayashi, M ;

Ohno, T ;

Kawada, T ;

Ikegami, H ;

Nishimura, M ;

Horio, F .

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2006, 70 (03) :677-683

[8]

HMG-CoA reductase inhibitor protects against in vivo arterial thrombosis by augmenting platelet-derived nitric oxide release in rats [J].

Yokoyama, S ;

Ikeda, H ;

Haramaki, N ;

Yasukawa, H ;

Katoh, A ;

Imaizumi, T .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 45 (04) :375-381

[9]

Pathophysiology of vascular endothelium and circulating platelets: implications for coronary revascularisation and treatment.[J].Giovanni Amoroso;Dirk J. van Veldhuisen;René A. Tio;Mario Mariani.International Journal of Cardiology.2001, 2

[10]

Angiographic patterns of in-stent restenosis - Classification and implications for long-term outcome [J].

Mehran, R ;

Dangas, G ;

Abizaid, AS ;

Mintz, GS ;

Lansky, AJ ;

Satler, LF ;

Pichard, AD ;

Kent, KM ;

Stone, GW ;

Leon, MB .

CIRCULATION, 1999, 100 (18) :1872-1878

← 1 →